ABL Bio Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ABL Bio Inc with three other
companies in this sector in KOREA (SOUTH) :
sales of 5.05 billion Korean Won [US$4.43 million]
Kang Stem Biotech Co Ltd
(6.00 billion Korean Won [US$5.27 million]
of which 53%
was Nonclinical CRO), and
Pangen Biotech Inc
(2.88 billion Korean Won [US$2.53 million]
of which 100%
was life sciences).